quinapril has been researched along with Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, TJ; Burrell, LM; Candido, R; Cooper, ME; Davis, BJ; Jandeleit-Dahm, K; Johnston, CI; Lassila, M | 1 |
| Athyros, VG; Avramidis, MJ; Didangelos, TP; Karamitsos, DT; Kontopoulos, AG; Mayroudi, MC; Papageorgiou, AA | 1 |
1 trial(s) available for quinapril and Diabetes Mellitus
| Article | Year |
|---|---|
Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Autonomic Nervous System Diseases; Diabetes Complications; Diabetes Mellitus; Diabetic Neuropathies; Double-Blind Method; Female; Heart Rate; Humans; Isoquinolines; Male; Middle Aged; Prospective Studies; Quinapril; Reference Values; Tetrahydroisoquinolines; Time Factors; Treatment Outcome | 1997 |
1 other study(ies) available for quinapril and Diabetes Mellitus
| Article | Year |
|---|---|
Anti-atherosclerotic and renoprotective effects of combined angiotensin-converting enzyme and neutral endopeptidase inhibition in diabetic apolipoprotein E-knockout mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Apolipoproteins E; Atherosclerosis; Biomarkers; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus; Glycated Hemoglobin; Kidney; Kidney Diseases; Male; Mice; Mice, Knockout; Neprilysin; Organ Size; Peptidyl-Dipeptidase A; Protease Inhibitors; Pyridines; Quinapril; Tetrahydroisoquinolines; Thiazepines | 2005 |